Survival benefit of induction immunosuppression in cystic fibrosis lung transplant recipients

Journal of Cystic Fibrosis

Volumn 14, Issue 1, 2015, Pages 104-110

  Kirkby, Stephen ^a,b,c   Whitson, Bryan A ^a   Wehr, Allison M ^a   Lehman, Amy M ^a   Higgins, Robert S ^a   Hayes, Don ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Cystic fibrosis; Immunosuppression; Induction; Lung transplantation; Survival

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY; HYBRID PROTEIN; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CYSTIC FIBROSIS; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOG RANK TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; ADOLESCENT; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; EVALUATION STUDY; FACTUAL DATABASE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTILYMPHOCYTE SERUM; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; DATABASES, FACTUAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANT RECIPIENTS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84918818913     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.05.010     Document Type: Article

References (16)

1. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373(9678):1891-1904.
2. Hayes D., Meyer K.C. Lung transplantation for advanced bronchiectasis. Semin Respir Crit Care Med 2010, 31(2):123-138.
3. Yusen R.D., Christie J.D., Edwards L.B., Kucheryavaya A.Y., Benden C., Dipchand A.I., et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report-2013; focus theme: age. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2013, 32(10):965-978. [Epub 2013/09/24].
4. Benden C., Edwards L.B., Kucheryavaya A.Y., Christie J.D., Dipchand A.I., Dobbels F., et al. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official pediatric lung and heart-lung transplantation report-2013; focus theme: age. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2013, 32(10):989-997. [Epub 2013/09/24].
5. Thabut G., Christie J.D., Mal H., Fournier M., Brugiere O., Leseche G., et al. Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation. American journal of respiratory and critical care medicine 2013, 187(12):1335-1340. [Epub 2013/04/18].
6. Aris R.M., Gilligan P.H., Neuringer I.P., Gott K.K., Rea J., Yankaskas J.R. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. American journal of respiratory and critical care medicine 1997, 155(5):1699-1704. [Epub 1997/05/01].
7. Hadjiliadis D., Steele M.P., Chaparro C., Singer L.G., Waddell T.K., Hutcheon M.A., et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2007, 26(8):834-838. [Epub 2007/08/19].
8. Helmi M., Love R.B., Welter D., Cornwell R.D., Meyer K.C. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest 2003, 123(3):800-808. [Epub 2003/03/12].
9. Chernenko S.M., Humar A., Hutcheon M., Chow C.W., Chaparro C., Keshavjee S., et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2006, 25(12):1447-1455. [Epub 2006/12/21].
10. Chalermskulrat W., Sood N., Neuringer I.P., Hecker T.M., Chang L., Rivera M.P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006, 61(6):507-513. [Epub 2006/04/08].
11. Orens J.B., Estenne M., Arcasoy S., Conte J.V., Corris P., Egan J.J., et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2006, 25(7):745-755. [Epub 2006/07/05].
12. Bhorade S.M., Stern E. Immunosuppression for lung transplantation. Proc Am Thorac Soc 2009, 6(1):47-53.
13. Cai J., Terasaki P.I. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data. Transplantation 2010, 90(12):1511-1515.
14. United Network for Organ Sharing/Organ Procurement and Transplantation Network Standard Transplant Analysis and Research Database Available from:. http://optn.transplant.hrsa.gov/data/about/OPTNDatabase.asp.
15. Hayes D., Kirkby S., Wehr A.M., Lehman A.M., McConnell P.I., Galantowicz M., et al. A Contemporary Analysis of Induction Immunosuppression in Pediatric Lung Transplant Recipients. Transplant international : official journal of the European Society for Organ Transplantation 2014, 27(2):211-218. [Epub 2013/11/19].
16. Jaksch P., Wiedemann D., Augustin V., Murakozy G., Scheed A., Kocher A.A., et al. Antithymocyte globulin induction therapy improves survival in lung transplantation for cystic fibrosis. Transplant international : official journal of the European Society for Organ Transplantation 2013, 26(1):34-41. [Epub 2012/11/14].